Skip to main content
Table of Contents
Print

How Does Cannabis Use Impact the Need for Surgical Interventions in EDS? 

Author: Dr. Clarissa Morton, PharmD

Cannabis and EDS surgery is an emerging topic in the treatment of Ehlers-Danlos Syndrome (EDS) , a condition that leads to joint instability, chronic pain, and tissue fragility. Many patients with EDS face the possibility of surgical interventions due to frequent dislocations, joint instability, and damaged tissues. As cannabis becomes more widely recognised for its therapeutic benefits, there is growing interest in understanding how cannabis and EDS surgery may interact and whether cannabis can reduce the need for surgery. 

While cannabis is not a cure for EDS, its potential to alleviate pain, reduce inflammation, and aid in tissue healing may influence the surgical need for some patients. Understanding how cannabis can play a role in symptom management may help reduce the need for invasive procedures. 

How Cannabis Use May Impact the Need for Surgery in EDS 

Here’s how cannabis and EDS surgery might intersect: 

  • Surgical need 
    For many EDS patients, joint instability and tissue damage can lead to the need for surgical repair. Cannabis may play a role in reducing the surgical need by managing symptoms like pain and inflammation. By alleviating pain and promoting relaxation, cannabis can help patients with EDS to engage in physical therapy and other treatments that may reduce the risk of surgery. 
  • Tissue repair 
    One of the potential benefits of cannabis is its ability to aid in tissue repair. Cannabis, particularly CBD, is known for its anti-inflammatory properties, which can help reduce swelling and promote healing of damaged tissues. For EDS patients, this could help improve the integrity of connective tissues and reduce the severity of symptoms, possibly decreasing the need for surgical interventions. 
  • Cannabis role in managing symptoms 
    The cannabis role in managing chronic pain and inflammation may help EDS patients maintain mobility and avoid the need for surgery. While cannabis won’t fix the underlying genetic issues causing EDS, it may offer symptomatic relief that prevents further damage and delays or eliminates the need for surgery in some cases. 

By integrating cannabis into a comprehensive treatment plan, cannabis and EDS surgery might be viewed as a way to manage the condition conservatively, reducing the reliance on surgical interventions. 

Providers like LeafEase can help guide EDS patients in using cannabis as part of their overall care plan, potentially reducing the need for invasive procedures. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Ehlers-Danlos Syndrome. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories